Sionna Therapeutics Cash Flow Statement 2023-2025 | SION

Fifteen years of historical annual cash flow statements for Sionna Therapeutics (SION).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
20242023
$-61.69$-47.26
$-2.33$-0.10
$14.31$4.44
$11.98$4.35
$0$0
$0$0
$0.47$0.16
$-4.62$0.16
$-3.08$-0.78
$-52.79$-43.70
$-0.03$-1.12
$0$0
$0$0
$-126.89$28.47
$0$0
$-126.89$28.47
$0$0
$-126.91$27.35
$0$0
$0$0
$0$0
$0.14$0.03
$181$0.03
$0$0
$-2.50$0
$179$0.03
$-0.73$-16.32
$3.71$2.26
$0$0